Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dentsply Sirona (XRAY) Change in Accured Expenses (2016 - 2025)

Dentsply Sirona (XRAY) has disclosed Change in Accured Expenses for 17 consecutive years, with -$8.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses rose 63.64% year-over-year to -$8.0 million, compared with a TTM value of -$74.0 million through Dec 2025, down 89.74%, and an annual FY2025 reading of -$74.0 million, down 89.74% over the prior year.
  • Change in Accured Expenses was -$8.0 million for Q4 2025 at Dentsply Sirona, up from -$31.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $75.0 million in Q3 2021 and bottomed at -$79.0 million in Q1 2021.
  • Average Change in Accured Expenses over 5 years is $750000.0, with a median of -$3.5 million recorded in 2023.
  • The sharpest move saw Change in Accured Expenses surged 314.29% in 2023, then tumbled 2300.0% in 2024.
  • Year by year, Change in Accured Expenses stood at $47.0 million in 2021, then plummeted by 119.15% to -$9.0 million in 2022, then soared by 111.11% to $1.0 million in 2023, then crashed by 2300.0% to -$22.0 million in 2024, then soared by 63.64% to -$8.0 million in 2025.
  • Business Quant data shows Change in Accured Expenses for XRAY at -$8.0 million in Q4 2025, -$31.0 million in Q3 2025, and $9.0 million in Q2 2025.